IP Verse

Coherus BioSciences, Inc. vs AbbVie Biotechnology Ltd. et al.

The detailed information for PTAB case with proceeding number IPR2017-00826 filed by Coherus BioSciences, Inc. against AbbVie Biotechnology Ltd. et al. on Jan 31, 2017. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2017-00826
Filing Date: Jan 31, 2017
Petitioner: Coherus BioSciences, Inc.
Respondent: AbbVie Biotechnology Ltd. et al.
Status: Terminated
Respondent Application Number: 14506576
Respondent Tech Center: 1600
Respondent Patent Number: 9085619
Termination Date: Apr 11, 2017

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Notice of Refund	Jun 5, 2017	PAPER	BOARD
PETITIONER'S REQUEST FOR REFUND OF POST-INSTITUTION FEES	May 25, 2017	PAPER	PETITIONER
Termination Decision Document	Apr 11, 2017	PAPER	BOARD
Order Conduct of the Proceeding	Apr 7, 2017	PAPER	BOARD
Petitioner's Unopposed Motion to Dismiss Petitions Without Prejudice	Apr 7, 2017	PAPER	PETITIONER
Petitioner's Updated Mandatory Notices	Mar 23, 2017	PAPER	PETITIONER
Patent Owner's Second Updated Mandatory Notices	Mar 17, 2017	PAPER	PATENT OWNER
Patent Owner's Updated Mandatory Notices	Feb 27, 2017	PAPER	PATENT OWNER
Notice of Accord Filing Date	Feb 24, 2017	PAPER	BOARD
Patent Owner's Power of Attorney	Feb 21, 2017	PAPER	PATENT OWNER
Patent Owner's Mandatory Notices	Feb 21, 2017	PAPER	PATENT OWNER
U.S. Patent No. 9,085,619	Jan 31, 2017	EXHIBIT	PETITIONER
Declaration of Klaus-Peter Radtke	Jan 31, 2017	EXHIBIT	PETITIONER
Declaration of David D. Sherry	Jan 31, 2017	EXHIBIT	PETITIONER
Adalimumab Product Info.	Jan 31, 2017	EXHIBIT	PETITIONER
U.S. Pub. No. 2003-0206898 (Fischkoff)	Jan 31, 2017	EXHIBIT	PETITIONER
Jefferis	Jan 31, 2017	EXHIBIT	PETITIONER
Butler	Jan 31, 2017	EXHIBIT	PETITIONER
Van Slyke	Jan 31, 2017	EXHIBIT	PETITIONER
Gokarn	Jan 31, 2017	EXHIBIT	PETITIONER
Dean	Jan 31, 2017	EXHIBIT	PETITIONER
PETITION FOR INTER PARTES REVIEW OF UNITED STATES PATENT NO. 9,085,619	Jan 31, 2017	PAPER	PETITIONER
Petitioner's Signed Power of Attorney	Jan 31, 2017	PAPER	PETITIONER
Fransson	Jan 31, 2017	EXHIBIT	PETITIONER
HUMIRA Label (Jan. 2003)	Jan 31, 2017	EXHIBIT	PETITIONER
HUMIRA Label (Jan. 2008)	Jan 31, 2017	EXHIBIT	PETITIONER
GAMIMUNE Label (Oct. 2005)	Jan 31, 2017	EXHIBIT	PETITIONER
Christensen	Jan 31, 2017	EXHIBIT	PETITIONER
Gelfand	Jan 31, 2017	EXHIBIT	PETITIONER
Annex A-The Humira Story	Jan 31, 2017	EXHIBIT	PETITIONER
U.S. Pub. No. 200300138417 (Kaisheva)	Jan 31, 2017	EXHIBIT	PETITIONER
Olthuis	Jan 31, 2017	EXHIBIT	PETITIONER
McCue	Jan 31, 2017	EXHIBIT	PETITIONER
Pros. History for U.S. Patent 9,085,619	Jan 31, 2017	EXHIBIT	PETITIONER
Pros. History for U.S. Patent 8,883,146-pt. 1 of 2	Jan 31, 2017	EXHIBIT	PETITIONER
Pros. History for U.S. Patent 8,883,146-pt. 2 of 2	Jan 31, 2017	EXHIBIT	PETITIONER
Pros. History for U.S. Patent 8,420,081-pt. 1 of 6	Jan 31, 2017	EXHIBIT	PETITIONER
U.S. Pros. Hist. App. No. 61-004,992	Jan 31, 2017	EXHIBIT	PETITIONER
Stoner	Jan 31, 2017	EXHIBIT	PETITIONER
U.S. Patent No. 6,090,382 (Salfeld)	Jan 31, 2017	EXHIBIT	PETITIONER
OCTAGAM Label (Mar. 2004)	Jan 31, 2017	EXHIBIT	PETITIONER
Injection Tips	Jan 31, 2017	EXHIBIT	PETITIONER
Laursen	Jan 31, 2017	EXHIBIT	PETITIONER
Frenken	Jan 31, 2017	EXHIBIT	PETITIONER
Nozaki	Jan 31, 2017	EXHIBIT	PETITIONER
Physicians Desk Reference	Jan 31, 2017	EXHIBIT	PETITIONER
Parslow	Jan 31, 2017	EXHIBIT	PETITIONER
Pros. History for U.S. Patent 8,420,081-pt. 2 of 6	Jan 31, 2017	EXHIBIT	PETITIONER
Pros. Hist. for U.S. Pt. 8,420,081-pt. 3 of 6	Jan 31, 2017	EXHIBIT	PETITIONER
Pros. Hist. for U.S. Pt. 8,420,081-pt. 4 of 6	Jan 31, 2017	EXHIBIT	PETITIONER
Pros. Hist. for U.S. Pt. 8,420,081-pt. 5 of 6	Jan 31, 2017	EXHIBIT	PETITIONER
Pros. Hist. U.S. Pt. 8,420,081-pt. 6 of 6	Jan 31, 2017	EXHIBIT	PETITIONER
Granolleras	Jan 31, 2017	EXHIBIT	PETITIONER
Gottlieb	Jan 31, 2017	EXHIBIT	PETITIONER
Schwartzman	Jan 31, 2017	EXHIBIT	PETITIONER
Development Pharmaceutics	Jan 31, 2017	EXHIBIT	PETITIONER
GAMUNEX Label (Nov. 2005)	Jan 31, 2017	EXHIBIT	PETITIONER
Schwartz	Jan 31, 2017	EXHIBIT	PETITIONER
HUMIRA Label (Nov. 2015)	Jan 31, 2017	EXHIBIT	PETITIONER
SYNAGIS Label (July 2004)	Jan 31, 2017	EXHIBIT	PETITIONER
Campath Label (Aug. 2006)	Jan 31, 2017	EXHIBIT	PETITIONER
Note for Guidance	Jan 31, 2017	EXHIBIT	PETITIONER
Clinical Pharmacology	Jan 31, 2017	EXHIBIT	PETITIONER
Fraunhofer Substantive Motion 3	Jan 31, 2017	EXHIBIT	PETITIONER
U.S. Pub. No. 2004-0033535 (Boyle)	Jan 31, 2017	EXHIBIT	PETITIONER
WO 1997-029131 (Salfeld)	Jan 31, 2017	EXHIBIT	PETITIONER
HUMIRA Label (Oct. 2016)	Jan 31, 2017	EXHIBIT	PETITIONER
Vivaglobin Label (Jan. 2006)	Jan 31, 2017	EXHIBIT	PETITIONER
CNJ-016 Label (Jan. 2010)	Jan 31, 2017	EXHIBIT	PETITIONER
GAMMAGARD LIQUID Label (April 2005)	Jan 31, 2017	EXHIBIT	PETITIONER
Flebogamma Label (Jan. 2004)	Jan 31, 2017	EXHIBIT	PETITIONER
Privigen Label (Oct. 2016)	Jan 31, 2017	EXHIBIT	PETITIONER
HepaGam B Summary Basis for Approval (Jan. 2006)	Jan 31, 2017	EXHIBIT	PETITIONER
AVASTIN Label (Feb. 2004)	Jan 31, 2017	EXHIBIT	PETITIONER
Vectibix Label (Sept. 2006)	Jan 31, 2017	EXHIBIT	PETITIONER
McDonnell	Jan 31, 2017	EXHIBIT	PETITIONER
Akers	Jan 31, 2017	EXHIBIT	PETITIONER
TYSABRI Label (Nov. 2004)	Jan 31, 2017	EXHIBIT	PETITIONER
Cleland	Jan 31, 2017	EXHIBIT	PETITIONER
U.S. Pub. No. 2016-0319011 (Gokarn)	Jan 31, 2017	EXHIBIT	PETITIONER
Hanna	Jan 31, 2017	EXHIBIT	PETITIONER
HUMIRA Label (Feb. 2008)	Jan 31, 2017	EXHIBIT	PETITIONER
HUMIRA Label (Nov. 2006)	Jan 31, 2017	EXHIBIT	PETITIONER
Meadows	Jan 31, 2017	EXHIBIT	PETITIONER
ENBREL Label (Sept. 2002)	Jan 31, 2017	EXHIBIT	PETITIONER
REMICADE Label (Aug. 1998)	Jan 31, 2017	EXHIBIT	PETITIONER
van de Putte	Jan 31, 2017	EXHIBIT	PETITIONER
HUMIRA Label (Oct. 2005)	Jan 31, 2017	EXHIBIT	PETITIONER
HUMIRA Label (Feb. 2007)	Jan 31, 2017	EXHIBIT	PETITIONER
ENBREL Label (Nov. 1998)	Jan 31, 2017	EXHIBIT	PETITIONER
Nash	Jan 31, 2017	EXHIBIT	PETITIONER
Tsourounis	Jan 31, 2017	EXHIBIT	PETITIONER
U.S. Patent No. 6,696,056 (Cheung)	Jan 31, 2017	EXHIBIT	PETITIONER
Yim	Jan 31, 2017	EXHIBIT	PETITIONER
Rowe	Jan 31, 2017	EXHIBIT	PETITIONER
WO 2006-138181 (Gokarn)	Jan 31, 2017	EXHIBIT	PETITIONER